Shandong Weigao Group Medical Polymer Stock

HKD6.74

3.58% today

Hong Kong, Aug 12, 10:08 am CET

ISIN

CNE100000171

Symbol

1066

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts Strategies

Shandong Weigao Group Medical Polymer Stock price

HKD6.74

-12.14 64.30% 5Y

Hong Kong, Closing price Tue, Aug 12 2025

-0.25 3.58%

ISIN

CNE100000171

Symbol

1066

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

HKD30.8b

Enterprise Value

HKD26.3b

Net debt

positive

Cash

HKD9.1b

Shares outstanding

4.6b

Valuation (TTM | estimate)

P/E

14.0 | 12.5

P/S

2.2 | 1.9

EV/Sales

1.8 | 1.6

EV/FCF

8.6

P/B

1.2

Dividends

DPS

HKD0.24

Yield 1Y | 5Y

3.4% | 1.7%

Growth 1Y | 5Y

28.2% | 12.0%

Payout 1Y | 3Y

47.1% | 36.5%

Increased

11 Years

Financials (TTM | estimate)

Revenue

HKD14.3b | HKD16.0b

EBITDA

- | HKD4.0b

EBIT

HKD3.0b | HKD3.0b

Net Income

HKD2.3b | HKD2.6b

Free Cash Flow

HKD3.0b

Growth (TTM | estimate)

Revenue

-1.1% | 12.1%

EBITDA

- | 7.7%

EBIT

7.0% | 15.3%

Net Income

3.2% | 13.5%

Free Cash Flow

-0.3%

Financial Health

Equity Ratio

68.3%

Return on Equity

8.7%

ROCE

9.5%

ROIC

10.7%

Debt/Equity

0.2

EPS

HKD0.5

FCF per Share

HKD0.7

Short interest

Employees

13k

Rev per Employee

HKD1.1m

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Shandong Weigao Group Medical Polymer Stock Analysis

Unlock Scores for Free

??

14 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:

12x Buy

86%

More details on Analyst Estimates Including Price Targets

14 Analysts have issued a Shandong Weigao Group Medical Polymer forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Shandong Weigao Group Medical Polymer

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	14,292 14,292	1% 1% 100%
- Direct Costs	7,105 7,105	1% 1% 50%
Gross Profit	7,186 7,186	1% 1% 50%
- Selling and Administrative Expenses	3,972 3,972	5% 5% 28%
- Research and Development Expense	683 683	5% 5% 5%
EBITDA	- -	- -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	2,989 2,989	7% 7% 21%
Net Profit	2,257 2,257	3% 3% 16%

In millions HKD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 12,719 full-time employees. The company went IPO on 2004-02-27. The firm operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.

Head office	China
Employees	12,719
Website	www.weigaoholding.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now